The International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA) is a major international AIDS conference which takes place in Africa. Its current biennial hosting alternates between Anglophone and Francophone African countries. The 2017 ICASA will be held in Côte d’Ivoire.
ICASA 2017 Abstract Categories
TRACK A: BASIC SCIENCE (BIOLOGY AND PATHOGENESIS)
Description: This track will encompass all aspects of fundamental HIV biology and the host response to HIV. Areas of focus will include HIV infection and replication, transmission, genetics, evolution, structure and function, pathogenesis, adaptive and innate immune responses to HIV, genetic susceptibility to HIV, interaction of micronutrients, co-infection and progress in animal models. Pre-clinical vaccine, microbicide, and drug development will be important themes of this track.
TRACK B: CLINICAL SCIENCE, TREATMENT AND CARE
Description: This track will analyze clinical features of opportunistic infections, malignancies, severe bacterial diseases, co-morbidities in people living with HIV. Issues in antiretroviral therapy, response to ART, adherence, retention, long term follow-up, management of side effects, ART in specific populations (adolescents, Elderly, pregnant women) will also be addressed. Emerging topics such as aging, frailty and in other age-related comorbidities such as cardiovascular, renal, neurocognitive, bone mineral and metabolic diseases will be discussed. Issues of resistance and management of failure including salvage therapy which is a concern in resources limited settings will be addressed
TRACK C: EPIDEMIOLOGY AND PREVENTION SCIENCE
Description: This track will focus on HIV and AIDS prevention research and issues related to the design, implementation and evaluation of prevention programs to reach the SDG. It will include examination of Research, methodological and programmatic advances in the continuum of prevention, particularly best practices in HIV prevention for vulnerable populations in resource-limited settings. Strategies to put HIV prevention research into practice, efforts to promote preparedness for bio-medical prevention technologies, and research on new prevention approaches including microbicides, vaccines, pre- and post-exposure prophylaxis, circumcision and other methods will be presented. This Track will also address co-morbidities (Hepatitis, Tuberculosis, and STI’s, communicable and emerging diseases
TRACK D: LAW, HUMAN RIGHTS, SOCIAL SCIENCE AND POLITICAL SCIENCE
Description: This track aims to highlight new knowledge and address gaps in the translation of behavioural and social science evidence into practice, and to contribute to the building of theory and understanding in HIV-related social science. The track also aims to promote understanding of the individual and social determinants of HIV-related risk, vulnerability and impact, to inform development of effective and sustainable HIV responses that are based on human dignity and individual entitlements. This track will feature research, analysis and evaluation on psychosocial factors that shape individual attitudes, experiences, and behaviors; social and structural factors that shape vulnerability and risk; social and cultural norms that underlie individual risk and community vulnerability; programmes that promote acceptation of human diversity and fast-track access to HIV and STI prevention, treatment, care and support; social and structural factors that shape vulnerability; and methods and outcomes of individual and community engagement, leadership, empowerment, and self-determination.
TRACK E: HEALTH SYSTEMS, ECONOMICS AND IMPLEMENTATION SCIENCE
Description: This track will aim to provide new insights into the status of the health systems and its capacity and challenges to expanding treatment and prevention in resource-limited settings. At the same time, issues related to health economics, integration of health programs, country ownership of national health and HIV programs, and advancement of a comprehensive and integrated approach to health and rights will be discussed. This Track must show the need for a holistic vision of the fight against the disease by the effective strengthening of health systems. The verticalization of the fight is not a proper and appropriate response in a context where we have recurrent epidemics.
Call for abstracts: 1 February to 28 July 2017
Early registration: 1 February to 31 March 2017
Regular registration: 1 April to 31 July 2017
Late registration: 1 August to 30 October 2017
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.
Thumbnail: ICASA 2017